Tracers' clinical application status in the sentinel lymph node biopsy of breast cancer
10.3760/cma.j.issn.1673-422X.2018.04.014
- VernacularTitle:示踪剂在乳腺癌前哨淋巴结活检中的临床应用
- Author:
Manman SHI
1
;
Chuang CHEN
;
Zhiyu LI
;
Shengrong SUN
Author Information
1. 430060,武汉大学人民医院乳甲外科
- Keywords:
Breast neoplasms;
Sentinel lymph node biopsy;
Tracer
- From:
Journal of International Oncology
2018;45(4):245-249
- CountryChina
- Language:Chinese
-
Abstract:
The treatment of breast cancer is becoming more individualized and minimally invasive,which makes sentinel lymph node biopsy becoming the standard treatment for axillary in patients with early-stage breast cancer who are negative in clinical axillary lymph nodes.Tracers image sentinel lymph nodes or lymphatic vessels for the successful detection of sentinel lymph node biopsy.Tracers selection is also more diverse,such as nano carbon mixed suspension,methylene blue,radioisotope,indocyanine green,etc.Different tracers and combined applications have their advantages and limitations.As for the selection of tracing methods,many factors need to be weighed.
